首页> 外文期刊>Journal of neuro-oncology. >The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo.
【24h】

The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo.

机译:溶瘤呼肠孤病毒加纽卡斯尔病病毒和呼肠孤病毒加细小病毒在体外和体内对U87和U373细胞的联合作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Previous results had documented oncolytic capacity of reovirus, parvovirus and Newcastle disease virus (NDV) on several tumor cell types. To test whether combinations of these viruses may increase this capacity, human U87- and U373-glioblastoma cells, in vitro or xenografted into immuno-compromised mice, were subjected to simultaneous double infections and analyzed. Our results show that reovirus (serotype-3) plus NDV (Hitcher-B1) and reovirus plus parvovirus-H1 lead to a significant increase in tumor cell killing in vitro in both cell lines (Kruskal-Wallis test, P < 0.01) and in vivo. Immunofluorescence and flow cytometry analyses demonstrated the simultaneous replication of the viruses in nearly all cells (>95%) after combined infection. These data thus indicate that a synergistic anti-tumor effect can be achieved by the combined infection with oncolytic viruses.
机译:先前的结果已证明呼肠孤病毒,细小病毒和新城疫病毒(NDV)在几种肿瘤细胞类型上的溶瘤能力。为了测试这些病毒的组合是否可以增加这种能力,对人U87和U373胶质母细胞瘤细胞进行体外或异种移植到免疫功能低下的小鼠中,同时进行双重感染并进行分析。我们的结果表明,呼肠孤病毒(血清型3)加NDV(Hitcher-B1)和呼肠孤病毒加细小病毒H1导致两种细胞系(Kruskal-Wallis检验,P <0.01)和体内。免疫荧光和流式细胞仪分析表明,在合并感染后,病毒几乎同时在几乎所有细胞(> 95%)中复制。因此,这些数据表明,通过溶瘤病毒的联合感染可以实现协同的抗肿瘤作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号